RE: DC When's your guess for this oneI really don't like to predict share price or timing. That said, my
personal opinion, which should be taken with a grain of salt, is this:
This weekend or early next week, we will get an update on the BLP25
program. Little or no reaction from the street.
End of the month, we will get to hear about Dr. Sandmaier's second
Theratope trial at the Fred Hutch (not certain yet, it could be a
rehash of the first trial, but we will know for sure very soon.). Keep
in mind that we really
haven't had any new Theratope news for a long, long time. Depending on
how good the news is, we could see a small pop in the share price. It
all depends, I think, on how many people are going to hear this news
and decide whether they should jump in and be ready for the phase III
unblinding in the third quarter, instead of waiting until a later
date. I find it hard to believe that we
wouldn't see a gradual rise up to that point as investors buy into the
story as we get closer to the moment of truth. But I have no idea what
the price will be in the third quarter.
But, of course, the biggest event, short term, that we are waiting for
is the announcement of a corporate alliance. When that occurs, I
expect to see a 20% to 30% immediate jump. Then a short term pullback
as daytraders and short term investors take their profits. After that
I expect the share price to gradually rise until the phase III trial
results are announced.
Your fellow investor,
DC Arnold